Nilotinib in locally advanced pigmented villonodular synovitis: a multicentre, open-label, single-arm, phase 2 trial

Author(s):
Gelderblom, H.; Cropet, C.; Chevreau, C.; Boyle, R.; Tattersall, M.; Stacchiotti, S.; Italiano, A.; Piperno-Neumann, S.; Cesne, A. le; Ferraresi, V.; Penel, N.; Duffaud, F.; Cassier, P.; Toulmonde, M.; Casali, P.; Taieb, S.; Guillemaut, S.; Metzger, S.; Perol, D.; Blay, J.Y.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-05-31
Language
English
Is part of
The Lancet Oncology (2018), Vol. 19, no. 5, p. 639-648
hdl
1887/96266
doi
10.1016/S1470-2045(18)30143-8